Waters (NYSE:WAT) Updates FY 2019 Earnings Guidance

Waters (NYSE:WAT) issued an update on its FY 2019 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $8.95-9.10 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $9.08. The company issued revenue guidance of $2.419929-2.44412829 billion, compared to the consensus revenue estimate of $2.46 billion.Waters also updated its FY19 guidance to $8.95-9.10 EPS.

Shares of NYSE:WAT traded down $3.34 during mid-day trading on Friday, hitting $208.42. 143,504 shares of the company traded hands, compared to its average volume of 562,939. The firm has a market capitalization of $14.82 billion, a price-to-earnings ratio of 25.14, a P/E/G ratio of 2.37 and a beta of 1.07. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.89 and a current ratio of 1.35. Waters has a 52-week low of $167.93 and a 52-week high of $255.21. The stock’s 50 day moving average price is $214.37.

Waters (NYSE:WAT) last announced its earnings results on Tuesday, July 30th. The medical instruments supplier reported $2.14 EPS for the quarter, beating the consensus estimate of $2.11 by $0.03. The business had revenue of $599.20 million for the quarter, compared to the consensus estimate of $601.46 million. Waters had a return on equity of 50.28% and a net margin of 24.09%. The company’s revenue was up .5% on a year-over-year basis. During the same period last year, the business posted $1.95 EPS. On average, equities analysts expect that Waters will post 9.01 earnings per share for the current fiscal year.

WAT has been the topic of several analyst reports. Bank of America downgraded Waters from a neutral rating to an underperform rating in a report on Tuesday, July 16th. Zacks Investment Research upgraded Waters from a sell rating to a hold rating and set a $217.00 target price on the stock in a report on Wednesday, May 22nd. ValuEngine downgraded Waters from a buy rating to a hold rating in a report on Thursday. UBS Group dropped their target price on Waters from $248.00 to $230.00 and set a neutral rating on the stock in a report on Wednesday, April 24th. Finally, Wolfe Research initiated coverage on Waters in a report on Thursday, May 30th. They set an underperform rating on the stock. Five research analysts have rated the stock with a sell rating, eight have issued a hold rating and one has issued a buy rating to the stock. Waters has a consensus rating of Hold and an average price target of $210.54.

About Waters

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Recommended Story: How to Invest in the Dividend Aristocrat Index

Earnings History and Estimates for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.